Latest Content

Explore innovative treatments for schizophrenia, depression, and dementia, focusing on new medications and holistic care approaches for better patient outcomes.

Need CME credit? We've got you covered.

Explore innovative approaches to mental health care, from jail diversion programs to addressing burnout in female physicians, enhancing patient outcomes.

Review the news from this year's Clinical Trials in Alzheimer's Disease conference.

A psychiatric reflects on a true gift, envisioning a future of hope, healing, and inclusion and celebrating the power of unity and compassion.

See the variety of commentary, news, and happenings in artificial intelligence (AI) and psychiatry throughout this year.

See the latest developments in narcolepsy research.

Syremis Therapeutics advances innovative drugs ST-905 and ST-901 for schizophrenia and major depressive disorder, aiming to transform mental health treatment.

During the holidays, can we blend tradition with modern media habits without sacrificing the meaning?

In this CME article, explore effective strategies for managing sleep disturbances in elite athletes, focusing on pharmacologic and nonpharmacologic interventions.

Reviva Pharmaceuticals announced FDA recommendations from their pre-NDA meeting on brilaroxazine for schizophrenia.

Discover engaging holiday reads that blend entertainment with profound insights, featuring classics and modern works that explore the human psyche.

An open letter urges lawmakers to regulate AI chatbots, highlighting their dangers to children's emotional development and mental health.